Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Sarcoma 1 Radiation Pneumonitis 1 Pancreatic Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Inflammatory Breast Neoplasms 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Doxorubicin 13 Gemcitabine 10 Cyclophosphamide 10 pazopanib 8 Filgrastim 8 Radiotherapy 7 Ifosfamide 7 Cisplatin 7 Irinotecan 6 Docetaxel 6 Radiation 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Trabectedin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4 Busulfan 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 temsirolimus 3 sargramostim 3 pembrolizumab 3 X-Rays 3 Sirolimus 3 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Neoadjuvant Therapy 3 Leucovorin 3 Dexrazoxane 3 Cryosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Sarcoma × nintedanib × Clear all

NCT02808247 2021-09-20

ANITA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡